Forbes October 19, 2024
Joe McKendrick

Is artificial intelligence delivering on all its proponents’ promises? Business leaders, for one, say they are still intrigued by generative AI, but their enthusiasm is waning, a recent survey out of Deloitte suggests. Senior executives and board members who have “high” and “very high” interest in generative AI were 67% and 57%, dropping eight and six points from the first quarter of this year, respectively.

“This is likely due to many genAI efforts still being at the pilot or proof-of-concept stage,” said Jim Rowan, head of AI at Deloitte. In total, a majority of respondents said their organization has moved fewer than 30% or of their generative AI solutions into production at this time. “This makes it harder to see...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Technology
Google digs deeper into healthcare AI: 5 notes
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
How AI Has And Will Continue To Transform Healthcare
AI Translates Nature into New Medicines | StartUp Health Insights: Week of Nov 26, 2024
Building AI trust: The key role of explainability

Share This Article